Medtronic PLC (MDT) Stock Analysis

MDT- NYSE (USA) Also traded in: Argentina, Brazil, Germany, Mexico, Switzerland, UK
Medtronic PLC

Currently 4/5

Business Predictability Rank: 4-Star
Back Testing Results:
Average gain of all 4-Star stocks: 9.8% per year.
% of Stocks that are in still loss if held for 10yrs: 8%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$75.71

0(0%) Volume: 4,367,492 1:01AM EST

Avg Vol (1m): 6,983,670

Warning! GuruFocus has detected 4 Severe Warning Signs with MDT. Click here to check it out.

Market Cap	103.95 B	P/E(ttm)	25.16
Enterprise Value	124.74 B	P/B	2.09

$75.71 (1y: +4%)

Today's Updates:

Gurus: Pioneer Investments 2016-12-31 Boosts Stake
Gurus: Robert Olstein 2016-12-31 Boosts Stake

RSS

Manual of Stocks™ Web APP

Manual of Stocks™

Sorry. Only PremiumPlus Member can access this feature.

Free Trial

Also traded in: Argentina, Brazil, Germany, Mexico, Switzerland, UK

Financial Strength : 5/10

		vs industry	vs history
Cash to Debt	0.35	NYSE:MDT's Cash to Debt is ranked lower than 81% of the 322 Companies in the Global Medical Devices industry. ( Industry Median: 2.26 vs. NYSE:MDT: 0.35 ) Ranked among companies with meaningful Cash to Debt only.	NYSE:MDT' s Cash to Debt Range Over the Past 10 Years Min: 0.15 Med: 0.6 Max: 9.58 Current: 0.35 0.15 - 9.58
Equity to Asset	0.51	NYSE:MDT's Equity to Asset is ranked lower than 67% of the 300 Companies in the Global Medical Devices industry. ( Industry Median: 0.63 vs. NYSE:MDT: 0.51 ) Ranked among companies with meaningful Equity to Asset only.	NYSE:MDT' s Equity to Asset Range Over the Past 10 Years Min: 0.37 Med: 0.57 Max: 0.82 Current: 0.51 0.37 - 0.82
Interest Coverage	4.19	NYSE:MDT's Interest Coverage is ranked lower than 86% of the 223 Companies in the Global Medical Devices industry. ( Industry Median: 73.78 vs. NYSE:MDT: 4.19 ) Ranked among companies with meaningful Interest Coverage only.	NYSE:MDT' s Interest Coverage Range Over the Past 10 Years Min: 3.82 Med: 10.69 Max: 16.28 Current: 4.19 3.82 - 16.28

F-Score: 6
Z-Score: 2.69
M-Score: -2.46
WACC vs ROIC	7.49% 7.22% WACC ROIC

Profitability & Growth : 8/10

		vs industry	vs history
Operating margin (%)	18.65	NYSE:MDT's Operating margin (%) is ranked higher than 87% of the 305 Companies in the Global Medical Devices industry. ( Industry Median: 2.73 vs. NYSE:MDT: 18.65 ) Ranked among companies with meaningful Operating margin (%) only.	NYSE:MDT' s Operating margin (%) Range Over the Past 10 Years Min: 16.71 Med: 23.03 Max: 30.17 Current: 18.65 16.71 - 30.17
Net-margin (%)	14.62	NYSE:MDT's Net-margin (%) is ranked higher than 84% of the 305 Companies in the Global Medical Devices industry. ( Industry Median: 2.25 vs. NYSE:MDT: 14.62 ) Ranked among companies with meaningful Net-margin (%) only.	NYSE:MDT' s Net-margin (%) Range Over the Past 10 Years Min: 12.27 Med: 18.81 Max: 22.78 Current: 14.62 12.27 - 22.78
ROE (%)	8.28	NYSE:MDT's ROE (%) is ranked higher than 64% of the 302 Companies in the Global Medical Devices industry. ( Industry Median: 1.47 vs. NYSE:MDT: 8.28 ) Ranked among companies with meaningful ROE (%) only.	NYSE:MDT' s ROE (%) Range Over the Past 10 Years Min: 6.72 Med: 19.6 Max: 27.52 Current: 8.28 6.72 - 27.52
ROA (%)	4.20	NYSE:MDT's ROA (%) is ranked higher than 64% of the 326 Companies in the Global Medical Devices industry. ( Industry Median: 0.36 vs. NYSE:MDT: 4.20 ) Ranked among companies with meaningful ROA (%) only.	NYSE:MDT' s ROA (%) Range Over the Past 10 Years Min: 3.43 Med: 10.42 Max: 14.3 Current: 4.2 3.43 - 14.3
ROC (Joel Greenblatt) (%)	60.16	NYSE:MDT's ROC (Joel Greenblatt) (%) is ranked higher than 89% of the 323 Companies in the Global Medical Devices industry. ( Industry Median: 4.32 vs. NYSE:MDT: 60.16 ) Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.	NYSE:MDT' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years Min: 51.21 Med: 66.98 Max: 82.85 Current: 60.16 51.21 - 82.85
Revenue Growth (3Y)(%)	7.80	NYSE:MDT's Revenue Growth (3Y)(%) is ranked higher than 67% of the 231 Companies in the Global Medical Devices industry. ( Industry Median: 3.80 vs. NYSE:MDT: 7.80 ) Ranked among companies with meaningful Revenue Growth (3Y)(%) only.	NYSE:MDT' s Revenue Growth (3Y)(%) Range Over the Past 10 Years Min: 4.2 Med: 12.6 Max: 17.9 Current: 7.8 4.2 - 17.9
EBITDA Growth (3Y)(%)	4.10	NYSE:MDT's EBITDA Growth (3Y)(%) is ranked higher than 53% of the 200 Companies in the Global Medical Devices industry. ( Industry Median: 2.20 vs. NYSE:MDT: 4.10 ) Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.	NYSE:MDT' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years Min: -15.5 Med: 9.6 Max: 24 Current: 4.1 -15.5 - 24
EPS Growth (3Y)(%)	-9.70	NYSE:MDT's EPS Growth (3Y)(%) is ranked lower than 69% of the 197 Companies in the Global Medical Devices industry. ( Industry Median: 2.70 vs. NYSE:MDT: -9.70 ) Ranked among companies with meaningful EPS Growth (3Y)(%) only.	NYSE:MDT' s EPS Growth (3Y)(%) Range Over the Past 10 Years Min: -9.7 Med: 13.5 Max: 27.1 Current: -9.7 -9.7 - 27.1

GuruFocus has detected 5 Warning Signs with Medtronic PLC $NYSE:MDT.

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» NYSE:MDT's 10-Y Financials

Financials (Next Earnings Date: 2017-05-25)

Revenue & Net Income

Cash & Debt

Oprt. Cash Flow & Free Cash Flow

Oprt. Cash Flow & Net Income

» NYSE:MDT's Warning Signs

Warning Signs

Subscribe to see Warning Signs. .

Start your free trial

» Details

Guru Trades

Q1 2016

Q2 2016

Q3 2016

Q4 2016

» Details

Insider Trades

Latest Guru Trades with MDT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Select Gurus: | Basic | Premium

| Premium Plus

No Entry found in the selected group of Gurus. You can

1. Modify your Personalized List of Gurus, or
2. Click on Premium above to check out all the Gurus, or
3. Click on Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry:	Medical Devices » Medical Devices NAICS: 334510 SIC: 3845
Compare:	NYSE:ABT, NYSE:SYK, NYSE:BSX, NAS:ISRG, NYSE:ZBH, NYSE:STJ, NYSE:EW, OTCPK:SNNUF, OTCPK:SONVY, NAS:ALGN, NYSE:TFX, NYSE:VAR, OTCPK:CHEOY, OTCPK:WILLF, NAS:ABMD, NAS:MASI, NAS:NUVA, OTCPK:EKTAF, NAS:IART, NYSE:NVRO » details
Traded in other countries:	MDT.Argentina, MDTC34.Brazil, 2M6.Germany, MDT N.Mexico, MDT.Switzerland, 0QYG.UK,

Medtronic PLC is engaged in providing medical technology alleviating pain, restoring health, and extending life of people. It currently functions in three operating segments that manufacture and sell device-based medical therapies.

Medtronic PLC was founded in 1949, incorporated as a Minnesota corporation in 1957. The Company is a medical technology company - alleviating pain, restoring health, and extending life for millions of people around the world. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, and ear, nose, and throat and diabetes conditions. The Company functions in four operating segments that manufacture and sell device-based medical therapies: Cardiac and Vascular Group; Minimally Invasive Therapies Group; Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group includes Cardiac Rhythm Disease Management that develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, including implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), products designed to reduce surgical site infections, information systems for the management of patients with CRDM devices, and an integrated health solutions business; Coronary which includes therapies to treat coronary artery disease (CAD) and hypertension. The products contained within this business include coronary stents and related delivery systems, including a broad line of balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories; The Structural Heart business offers a comprehensive line of products and therapies to treat a variety of heart valve disorders. The Endovascular business is comprised of a comprehensive line of products and therapies to treat aortic disease (such as aneurysms, dissections, and transections) as well as peripheral vascular disease (PVD). Its products include endovascular stent graft systems, peripheral stent and angioplasty systems, and carotid embolic protection systems for the treatment of vascular disease outside the heart. The Minimally Invasive Therapies Group is composed of the Surgical Solutions and Patient Monitoring & Recovery divisions. With a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications, the group looks to enhance patient outcomes through minimally invasive solutions. The Restorative Therapies Group includes Spine business which develops, manufactures, and markets a comprehensive line of medical devices and implants used in the treatment of the spine and musculoskeletal system. Its products and therapies treat a variety of conditions affecting the spine, including degenerative disc disease, spinal deformity, spinal tumors, fractures of the spine, and stenosis. Its Spine business also provides biologic solutions for the orthopedic and dental markets. Its Neuromodulation business includes implantable neurostimulation and targeted drug delivery systems for the management of ch

Guru Investment Theses on Medtronic PLC

Gabelli Funds Comments on Medtronic Plc - Aug 04, 2016

Medtronic plc (NYSE:MDT) (1.7%) (MDT – $75.00 – NYSE) cemented its position as the largest manufacturer of medical devices in the world with last year’s $50 billion acquisition of Covidien. This deal, structured as a tax inversion, should both improve the company’s growth rate and give it better access to its global cash flow. Meanwhile, Medtronic is accelerating its own growth rate through improved management execution and a full pipeline of new heart valves, drug coated balloons, and defibrillators. Medtronic will be the partner of choice for hospitals going forward, and the Covidien deal will allow the company to continue to return at least 50% of its cash flow to shareholders via share buybacks and dividends.

From the Gabelli Dividend Growth Fund second quarter 2016 commentary.

Check out Mario Gabelli latest stock trades

Ratios

		vs industry	vs history
P/E(ttm)	25.16	MDT's P/E(ttm) is ranked higher than 51% of the 172 Companies in the Global Medical Devices industry. ( Industry Median: 25.71 vs. MDT: 25.16 ) Ranked among companies with meaningful P/E(ttm) only.	MDT' s P/E(ttm) Range Over the Past 10 Years Min: 10.17 Med: 20.47 Max: 54.09 Current: 25.16 10.17 - 54.09
Forward P/E	15.08	MDT's Forward P/E is ranked higher than 91% of the 55 Companies in the Global Medical Devices industry. ( Industry Median: 24.21 vs. MDT: 15.08 ) Ranked among companies with meaningful Forward P/E only.	N/A
PE(NRI)	25.16	MDT's PE(NRI) is ranked higher than 51% of the 173 Companies in the Global Medical Devices industry. ( Industry Median: 25.71 vs. MDT: 25.16 ) Ranked among companies with meaningful PE(NRI) only.	MDT' s PE(NRI) Range Over the Past 10 Years Min: 10.17 Med: 20.47 Max: 54.09 Current: 25.16 10.17 - 54.09
Price/Owner Earnings (ttm)	19.59	MDT's Price/Owner Earnings (ttm) is ranked higher than 73% of the 109 Companies in the Global Medical Devices industry. ( Industry Median: 30.20 vs. MDT: 19.59 ) Ranked among companies with meaningful Price/Owner Earnings (ttm) only.	MDT' s Price/Owner Earnings (ttm) Range Over the Past 10 Years Min: 9.24 Med: 18.81 Max: 51.3 Current: 19.59 9.24 - 51.3
P/B	2.09	MDT's P/B is ranked higher than 64% of the 299 Companies in the Global Medical Devices industry. ( Industry Median: 3.05 vs. MDT: 2.09 ) Ranked among companies with meaningful P/B only.	MDT' s P/B Range Over the Past 10 Years Min: 1.78 Med: 2.86 Max: 6.3 Current: 2.09 1.78 - 6.3
P/S	3.65	MDT's P/S is ranked lower than 57% of the 289 Companies in the Global Medical Devices industry. ( Industry Median: 3.10 vs. MDT: 3.65 ) Ranked among companies with meaningful P/S only.	MDT' s P/S Range Over the Past 10 Years Min: 1.93 Med: 3.48 Max: 5.54 Current: 3.65 1.93 - 5.54
PFCF	21.60	MDT's PFCF is ranked higher than 60% of the 108 Companies in the Global Medical Devices industry. ( Industry Median: 27.61 vs. MDT: 21.60 ) Ranked among companies with meaningful PFCF only.	MDT' s PFCF Range Over the Past 10 Years Min: 9.19 Med: 14.51 Max: 64.89 Current: 21.6 9.19 - 64.89
POCF	17.41	MDT's POCF is ranked higher than 54% of the 134 Companies in the Global Medical Devices industry. ( Industry Median: 18.57 vs. MDT: 17.41 ) Ranked among companies with meaningful POCF only.	MDT' s POCF Range Over the Past 10 Years Min: 8.14 Med: 12.71 Max: 28.33 Current: 17.41 8.14 - 28.33
EV-to-EBIT	21.57	MDT's EV-to-EBIT is ranked higher than 51% of the 167 Companies in the Global Medical Devices industry. ( Industry Median: 22.04 vs. MDT: 21.57 ) Ranked among companies with meaningful EV-to-EBIT only.	MDT' s EV-to-EBIT Range Over the Past 10 Years Min: 8.7 Med: 15.8 Max: 30.9 Current: 21.57 8.7 - 30.9
EV-to-EBITDA	14.38	MDT's EV-to-EBITDA is ranked higher than 56% of the 177 Companies in the Global Medical Devices industry. ( Industry Median: 16.65 vs. MDT: 14.38 ) Ranked among companies with meaningful EV-to-EBITDA only.	MDT' s EV-to-EBITDA Range Over the Past 10 Years Min: 7.4 Med: 13.2 Max: 21.7 Current: 14.38 7.4 - 21.7
PEG	6.20	MDT's PEG is ranked lower than 78% of the 77 Companies in the Global Medical Devices industry. ( Industry Median: 2.41 vs. MDT: 6.20 ) Ranked among companies with meaningful PEG only.	MDT' s PEG Range Over the Past 10 Years Min: 1.1 Med: 1.89 Max: 18.15 Current: 6.2 1.1 - 18.15
Shiller P/E	26.32	MDT's Shiller P/E is ranked higher than 81% of the 48 Companies in the Global Medical Devices industry. ( Industry Median: 46.48 vs. MDT: 26.32 ) Ranked among companies with meaningful Shiller P/E only.	MDT' s Shiller P/E Range Over the Past 10 Years Min: 14.49 Med: 22.27 Max: 42.29 Current: 26.32 14.49 - 42.29
Current Ratio	2.35	MDT's Current Ratio is ranked lower than 51% of the 320 Companies in the Global Medical Devices industry. ( Industry Median: 2.45 vs. MDT: 2.35 ) Ranked among companies with meaningful Current Ratio only.	MDT' s Current Ratio Range Over the Past 10 Years Min: 0.88 Med: 2.44 Max: 6.8 Current: 2.35 0.88 - 6.8
Quick Ratio	1.96	MDT's Quick Ratio is ranked higher than 52% of the 320 Companies in the Global Medical Devices industry. ( Industry Median: 1.81 vs. MDT: 1.96 ) Ranked among companies with meaningful Quick Ratio only.	MDT' s Quick Ratio Range Over the Past 10 Years Min: 0.66 Med: 1.95 Max: 6.46 Current: 1.96 0.66 - 6.46
Days Inventory	143.11	MDT's Days Inventory is ranked lower than 54% of the 287 Companies in the Global Medical Devices industry. ( Industry Median: 130.88 vs. MDT: 143.11 ) Ranked among companies with meaningful Days Inventory only.	MDT' s Days Inventory Range Over the Past 10 Years Min: 132.14 Med: 142.57 Max: 164.01 Current: 143.11 132.14 - 164.01
Days Sales Outstanding	71.22	MDT's Days Sales Outstanding is ranked lower than 52% of the 272 Companies in the Global Medical Devices industry. ( Industry Median: 67.65 vs. MDT: 71.22 ) Ranked among companies with meaningful Days Sales Outstanding only.	MDT' s Days Sales Outstanding Range Over the Past 10 Years Min: 70.41 Med: 81.9 Max: 92.09 Current: 71.22 70.41 - 92.09
Days Payable	66.61	MDT's Days Payable is ranked higher than 56% of the 255 Companies in the Global Medical Devices industry. ( Industry Median: 57.31 vs. MDT: 66.61 ) Ranked among companies with meaningful Days Payable only.	MDT' s Days Payable Range Over the Past 10 Years Min: 32.49 Med: 51.72 Max: 93.14 Current: 66.61 32.49 - 93.14

Dividend & Buy Back

		vs industry	vs history
Dividend Yield	2.22	MDT's Dividend Yield is ranked higher than 68% of the 187 Companies in the Global Medical Devices industry. ( Industry Median: 1.66 vs. MDT: 2.22 ) Ranked among companies with meaningful Dividend Yield only.	MDT' s Dividend Yield Range Over the Past 10 Years Min: 0.75 Med: 1.89 Max: 2.93 Current: 2.22 0.75 - 2.93
Dividend Payout	0.54	MDT's Dividend Payout is ranked higher than 66% of the 121 Companies in the Global Medical Devices industry. ( Industry Median: 0.39 vs. MDT: 0.54 ) Ranked among companies with meaningful Dividend Payout only.	MDT' s Dividend Payout Range Over the Past 10 Years Min: 0.18 Med: 0.31 Max: 0.61 Current: 0.54 0.18 - 0.61
Dividend Growth (3y)	13.50	MDT's Dividend Growth (3y) is ranked higher than 61% of the 76 Companies in the Global Medical Devices industry. ( Industry Median: 9.10 vs. MDT: 13.50 ) Ranked among companies with meaningful Dividend Growth (3y) only.	MDT' s Dividend Growth (3y) Range Over the Past 10 Years Min: 7.6 Med: 14.9 Max: 24.9 Current: 13.5 7.6 - 24.9
Forward Dividend Yield	2.28	MDT's Forward Dividend Yield is ranked higher than 73% of the 175 Companies in the Global Medical Devices industry. ( Industry Median: 1.52 vs. MDT: 2.28 ) Ranked among companies with meaningful Forward Dividend Yield only.	N/A
Yield on cost (5-Year)	3.61	MDT's Yield on cost (5-Year) is ranked higher than 79% of the 219 Companies in the Global Medical Devices industry. ( Industry Median: 1.97 vs. MDT: 3.61 ) Ranked among companies with meaningful Yield on cost (5-Year) only.	MDT' s Yield on cost (5-Year) Range Over the Past 10 Years Min: 1.22 Med: 3.07 Max: 4.76 Current: 3.61 1.22 - 4.76
3-Year Average Share Buyback Ratio	-11.30	MDT's 3-Year Average Share Buyback Ratio is ranked lower than 69% of the 208 Companies in the Global Medical Devices industry. ( Industry Median: -3.90 vs. MDT: -11.30 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.	MDT' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years Min: -11.3 Med: 1 Max: 2.5 Current: -11.3 -11.3 - 2.5

Valuation & Return

		vs industry	vs history
Price/Projected FCF	1.20	MDT's Price/Projected FCF is ranked higher than 78% of the 118 Companies in the Global Medical Devices industry. ( Industry Median: 2.06 vs. MDT: 1.20 ) Ranked among companies with meaningful Price/Projected FCF only.	MDT' s Price/Projected FCF Range Over the Past 10 Years Min: 0.76 Med: 1.41 Max: 6.95 Current: 1.2 0.76 - 6.95
Price/DCF (Earnings Based)	2.35	MDT's Price/DCF (Earnings Based) is ranked lower than 52% of the 21 Companies in the Global Medical Devices industry. ( Industry Median: 2.17 vs. MDT: 2.35 ) Ranked among companies with meaningful Price/DCF (Earnings Based) only.	N/A
Price/Median PS Value	1.06	MDT's Price/Median PS Value is ranked lower than 56% of the 225 Companies in the Global Medical Devices industry. ( Industry Median: 1.00 vs. MDT: 1.06 ) Ranked among companies with meaningful Price/Median PS Value only.	MDT' s Price/Median PS Value Range Over the Past 10 Years Min: 0.67 Med: 1.47 Max: 3.64 Current: 1.06 0.67 - 3.64
Earnings Yield (Greenblatt) (%)	4.66	MDT's Earnings Yield (Greenblatt) (%) is ranked higher than 74% of the 312 Companies in the Global Medical Devices industry. ( Industry Median: 0.90 vs. MDT: 4.66 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.	MDT' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years Min: 3.2 Med: 6.3 Max: 11.5 Current: 4.66 3.2 - 11.5
Forward Rate of Return (Yacktman) (%)	8.76	MDT's Forward Rate of Return (Yacktman) (%) is ranked lower than 52% of the 124 Companies in the Global Medical Devices industry. ( Industry Median: 8.94 vs. MDT: 8.76 ) Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.	MDT' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years Min: 7.2 Med: 14.2 Max: 19.5 Current: 8.76 7.2 - 19.5

More Statistics

Revenue (TTM) (Mil) $	29,012
EPS (TTM) $	3.01
Beta	0.85
Short Percentage of Float	0.70%
52-Week Range $	69.35 - 89.27
Shares Outstanding (Mil)	1,373.05

Analyst Estimate

	Apr17	Apr18	Apr19
Revenue (Mil $)	29,643	30,954	32,427
EPS ($)	4.56	5.02	5.67
EPS w/o NRI ($)	4.56	5.02	5.67
EPS Growth Rate (3Y to 5Y Estimate)	7.52%
Dividends Per Share ($)	1.64	1.90	2.28

» More Articles for MDT

Headlines

Articles On GuruFocus.com

Top 7 Dividend Health Care Stocks Jan 05 2017

52-Week Company Lows Jan 05 2017

52-Week Company Lows Dec 29 2016

The 10 Best Dividend Aristocrats for 2017 and Beyond Dec 23 2016

52-Week Company Lows Dec 22 2016

Weekly Top Insider Buys Highlights Dec 16 2016

52-Week Company Lows Dec 15 2016

52-Week Company Lows Dec 08 2016

52-Week Company Lows Dec 01 2016

Weekly Top Insider Buys Highlight for the Week of Nov. 25 Nov 27 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Mobile App Email Alerts Referral Program Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

Value Screens

Downloads | Tools

Strategies

Market Valuation

By Country

Articles

Submit Articles

Financial Strength : 5/10

Profitability & Growth : 8/10

Financials (Next Earnings Date: 2017-05-25)

Warning Signs

Guru Trades

MDT Guru Trades in Q1 2016

MDT Guru Trades in Q2 2016

MDT Guru Trades in Q3 2016

MDT Guru Trades in Q4 2016

Insider Trades

Latest Guru Trades with MDT

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Guru Investment Theses on Medtronic PLC

Gabelli Funds Comments on Medtronic Plc - Aug 04, 2016

Top Ranked Articles about Medtronic PLC

Ratios

Dividend & Buy Back

Valuation & Return

More Statistics

Analyst Estimate

Headlines

Personalized Checklist

Value Screens

Downloads | Tools

Strategies

Market Valuation

By Country

Articles

Submit Articles

Financial Strength : 5/10

Profitability & Growth : 8/10

Financials .earnings_date { color: #000000; font-size: 12px; font-weight: normal; } (Next Earnings Date: 2017-05-25)

Warning Signs

Guru Trades

MDT Guru Trades in Q1 2016

MDT Guru Trades in Q2 2016

MDT Guru Trades in Q3 2016

MDT Guru Trades in Q4 2016

Insider Trades

Latest Guru Trades with MDT

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Guru Investment Theses on Medtronic PLC

Gabelli Funds Comments on Medtronic Plc - Aug 04, 2016

Top Ranked Articles about Medtronic PLC

Ratios

Dividend & Buy Back

Valuation & Return

More Statistics

Analyst Estimate

Headlines

Personalized Checklist

Financials (Next Earnings Date: 2017-05-25)